Name: Latest research reports of Gland Pharma Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Gland Pharma Ltd.
Rating: 3
Author: Axis Direct

Gland Pharma Ltd.

NSE: GLAND | BSE: 543245 | ISIN: INE068V01023 | Industry: Pharmaceuticals
| Mid-range Performer

1623.1000 -10.90 (-0.67%)

NSE Mar 26, 2025 15:31 PM

26.92% Fall from 52W High

Volume: 97,701

High vol. this week

Gland Pharma Ltd.

30 Oct 2022

1623.10

-0.67%

Result Update:Gland Pharma

Hold: Gland Pharma Ltd.

Target

Axis Direct

We expect similar growth for GLAND in core markets over a longer period and high double digits growth in India &RoW. FY23 seems to be flat revenue growth due to increased competition and moderation demand for GLAND, therefore we recommend HOLD with TP of Rs 2,100.

Gland Pharma Ltd. has an average target of 1710.00 from 2 brokers.